Ganga Pharmaceuticals Ltd vs Remus Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Ganga Pharmaceuticals Ltd is ₹ 12 as of 12 Feb 15:30 . The P/E Ratio of Ganga Pharmaceuticals Ltd is 0 as of March 2024 .The P/E Ratio of Remus Pharmaceuticals Ltd is 49.4 as of March 2024 . The Market Cap of Ganga Pharmaceuticals Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Remus Pharmaceuticals Ltd is ₹ 1016 crore as of March 2024 . The Revenue of Ganga Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Remus Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Ganga Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Remus Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Ganga Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Remus Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 . The Dividend Payout of Ganga Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Remus Pharmaceuticals Ltd changed from 2.56 % on March 2023 to 4.44 % on March 2025 . This represents a CAGR of 20.15% over 3 years .

About Ganga Pharmaceuticals Ltd

Ganga Pharmaceuticals Ltd was incorporated as a Public Limited Company in Aug.'94 and promoted by Brij Mohan Sharma. he Company is engaged in the business of manufacturing & trading in Pharmaceuticals & allied products (Ayurveda). In Apr.'95, the company took over Ganga pharmaceuticals, a proprietory concern (owned by the same promoter), which was manufacturing and marketing ayurvedic products since the last two decades. The company which manufactures ayurvedic medicines, started commercial production in Apr.'95.
In Jul.'96, it came out with a public issue to part-finance the expansion programme involving setting up of a new manufacturing unit for the manufacture of ayurvedic medicines at Murbad, Maharashtra. The company which commenced exports in Jan.'96, has marketing arrangements with parties located in Saudi Arabia, Dubai, Italy, Romania and Russia to market its products in their respective regions.

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

FAQs for the comparison of Ganga Pharmaceuticals Ltd and Remus Pharmaceuticals Ltd

Which company has a larger market capitalization, Ganga Pharmaceuticals Ltd or Remus Pharmaceuticals Ltd?

Market cap of Ganga Pharmaceuticals Ltd is 7 Cr while Market cap of Remus Pharmaceuticals Ltd is 807 Cr

What are the key factors driving the stock performance of Ganga Pharmaceuticals Ltd and Remus Pharmaceuticals Ltd?

The stock performance of Ganga Pharmaceuticals Ltd and Remus Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ganga Pharmaceuticals Ltd and Remus Pharmaceuticals Ltd?

As of May 4, 2026, the Ganga Pharmaceuticals Ltd stock price is INR ₹12.0. On the other hand, Remus Pharmaceuticals Ltd stock price is INR ₹685.3.

How do dividend payouts of Ganga Pharmaceuticals Ltd and Remus Pharmaceuticals Ltd compare?

To compare the dividend payouts of Ganga Pharmaceuticals Ltd and Remus Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.